Latanoprost-induced iris color darkening: A case report with long-term follow-up

Journal of Glaucoma

Volumn 9, Issue 1, 2000, Pages 95-98

  Camras, Carl B ^a,b,c   Neely, Donna G ^a   Weiss, Ellen L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Glaucoma; Iris color; Latanoprost; Prostaglandins; Sympathetic insufficiency

Indexed keywords

COCAINE; HYDROXYAMPHETAMINE; LATANOPROST;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFECT; DRUG WITHDRAWAL; EYE COLOR; EYE PHOTOGRAPHY; GLAUCOMA; HUMAN; HYPERPIGMENTATION; INTRAOCULAR PRESSURE; IRIS BLOOD VESSEL; MALE; PRIORITY JOURNAL; PUPIL; SYMPATHETIC INNERVATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELD;

EID: 0034445864     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200002000-00016     Document Type: Article

References (8)

1. Wistrand P, Stjernschantz J, Olsson K. The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color. Surv Ophthalmol 1997;41:S129-S38.
2. Zhan G-L, Toris CB, Camras CB, Wang Y-L, Bito LZ. Prostaglandin-induced iris color darkening. An experimental model. Arch Ophthalmol 1998;116:1065-8.
3. Laties AM. Ocular melanin and the adrenergic innervation to the eye. Trans Am Ophthalmol Soc 1974;72:560-605.
4. Camras CB, the United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States. Ophthalmology 1996;103:138-47.
5. Diesenhouse MC, Palay DA, Newman NJ, To K, Albert DM. Acquired heterochromia with Horner Syndrome in two adults. Ophthalmology 1992;99:1815-7.
6. Zhan G-L, Ohia SE, Camras CB, Ohia EO, Wang Y-L. Superior cervical ganglionectomy-induced lowering of intraocular pressure in rabbits: role of prostaglandins and neuropeptide Y. General Pharmacol 1999;32:189-94.
7. Dryja TP, Albert DM. Lack of adrenergic influence on the pigmentation of iris nevus cells. Arch Ophthalmol 1980;98:1996.
8. Holz FG, Piguet B, Minassian DC, Bird AC, Weale RA. Decreasing stromal iris pigmentation as a risk factor for age-related macular degeneration. Am J Ophthalmol 1994;117:19-23.